The dilemma of counseling patients about poor prognosis: live birth after IVF with autologous oocytes in a 43-year-old woman with FSH levels above 30 mIU/mL

[1]  M. Sauer,et al.  Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion. , 2019, Fertility and sterility.

[2]  A. Quaas,et al.  Low-dose human chorionic gonadotropin alone can complete follicle maturity: successful application to modified natural cycle in vitro fertilization. , 2016, Fertility and sterility.

[3]  J. Gingold,et al.  Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels: waiting for a “better" month conveys limited retrieval benefits , 2015, Reproductive Biology and Endocrinology.

[4]  S. Klock.  When treatment appears futile: the role of the mental health professional and end-of-treatment counseling. , 2015, Fertility and sterility.

[5]  W. Schlaff.  Autonomy, futility, and good business in reproductive medicine: is the slope getting more slippery? , 2015, Fertility and sterility.

[6]  R. Chattopadhyay,et al.  Live birth in a 50-year-old woman following in vitro fertilization-embryo transfer with autologous oocytes: a rare case report. , 2015, Fertility and sterility.

[7]  M. Trolice.  Live birth from a 46-year-old using fresh autologous oocytes through in vitro fertilization. , 2014, Fertility and sterility.

[8]  H. Tournaye,et al.  Assisted reproduction using donor spermatozoa in women aged 40 and above: the high road or the low road? , 2013, Reproductive biomedicine online.

[9]  P. Haentjens,et al.  Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. , 2009, Human reproduction.

[10]  B. Mol,et al.  A systematic review of tests predicting ovarian reserve and IVF outcome. , 2006, Human reproduction update.

[11]  L. Parmegiani,et al.  Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. , 2005, Fertility and sterility.

[12]  C. Flamigni,et al.  Live birth after IVF in a 46-year-old woman. , 2005, Reproductive biomedicine online.

[13]  D. Clappbsnrn.  Helping patients know when ?enough is enough? , 2004 .

[14]  J. Donnez,et al.  In Vitro Fertilization Outcome According to Age and Follicle-Stimulating Hormone Levels on Cycle Day 3 , 1999, Journal of Assisted Reproduction and Genetics.

[15]  T. Gürgan,et al.  Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol. , 1997, Fertility and sterility.

[16]  J. Nisker,et al.  Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. , 1996, Fertility and sterility.

[17]  M. Sauer,et al.  Counseling the infertile couple: when enough is enough. , 1991, Obstetrics and gynecology.